Epigenetic Characterization of Immune Cells in Parkinson s disease and Prodromal Stages (EpiGEN PD) Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Parkinson Disease
  • Age: Between 30 Year(s) - 75 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Male or female 30-75 years of age (inclusive)
    2. Subjects with one or more of the following features:
      • Hyposmia: As assessed by clinical history and/or previously performed University of Pennsylvania Smell Test (UPSIT)
      • REM Behavior Sleep Disorder (RBD): Based on clinical history and/or positive polysomnography
      • Known genetic risk factor for PD: Defined as a carrier of a reduced penetrance PD-related genetic mutation such as mutations of the GBA and LRRK2 gene

You may not be eligible for this study if the following are true:

    1. Subject with a diagnosis of Parkinson’s disease, atypical parkinsonism (i.e. progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy) or secondary parkinsonism (i.e. normal pressure hydrocephalus, drug-induced parkinsonism)



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.